Eribulin

Eribulin is a medication used in cancer treatment, specifically for metastatic breast cancer. It works by slowing the growth of cancer cells, offering a targeted approach to managing advanced disease.

Eribulin is primarily used in the treatment of metastatic breast cancer. It is designed to interfere with the growth of cancer cells, making it a valuable option for patients who have limited treatment choices. The medication is administered intravenously, allowing it to directly target cancer cells in the body.

Common effects of Eribulin may include fatigue, nausea, and hair loss. Some patients may also experience peripheral neuropathy, which can cause tingling or numbness in the hands and feet. These effects can vary in severity and duration, depending on individual responses to the medication.

Eribulin should be handled with care, as it is a potent medication. It is important to follow the advice of a healthcare professional regarding its use. Patients should be monitored regularly to manage any potential side effects and ensure the medication is working as intended.

Eribulin may interact with other medications, particularly those that affect liver function or the immune system. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Eribulin.